Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,246,641
  • Shares Outstanding, K 119,029
  • Annual Sales, $ 23,870 K
  • Annual Income, $ -290,060 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.78
  • Price/Sales 261.77
  • Price/Cash Flow N/A
  • Price/Book 15.63
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.23
  • Most Recent Earnings $-0.45 on 10/31/19
  • Next Earnings Date 10/29/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.47
  • Number of Estimates 6
  • High Estimate -0.43
  • Low Estimate -0.51
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +16.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.02 +0.88%
on 09/11/20
52.53 -0.10%
on 09/30/20
+0.15 (+0.29%)
since 08/28/20
3-Month
26.86 +95.38%
on 08/11/20
52.53 -0.10%
on 09/30/20
+19.21 (+57.74%)
since 06/30/20
52-Week
12.21 +329.81%
on 10/02/19
52.53 -0.10%
on 09/30/20
+39.52 (+304.94%)
since 09/30/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 52.56
1st Resistance Point 52.52
Last Price 52.48
1st Support Level 52.45
2nd Support Level 52.42
3rd Support Level N/A

See More

52-Week High 52.53
Last Price 52.48
Fibonacci 61.8% 37.13
Fibonacci 50% 32.37
Fibonacci 38.2% 27.61
52-Week Low 12.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar